Systems and methods for making non-invasive physiological assessments by detecting induced acoustic emissions

• US 20060079773A1
• Filed: 02/04/2005
• Published: 04/13/2006
• Est. Priority Date: 11/28/2000
• Status: Abandoned Application

• Current Assignee: PhysioSonics, Inc., University of Washington
• Original Assignee: Allez Physionix Ltd., University of Washington
• Inventors: Mourad, Pierre D., Kliot, Michel, Frederickson, Robert C.A.
• Application Number:
  US11/050,993
• Publication Number:
  US 20060079773A1
• Time in Patent Office: Days
• US Class Current: 600/438
• CPC Class Codes: A61B 5/0051 by applying vibrations
• CPC Class Codes: A61B 5/031 Intracranial pressure
• CPC Class Codes: A61B 5/4058 for evaluating the central nervous system A61B5/4806, A61B5/4821 take precedence
• CPC Class Codes: A61B 5/4064 Evaluating the brain A61B5/031, A61B5/369, A61B5/14553 take precedence
• CPC Class Codes: A61B 5/415 the glands, e.g. tonsils, adenoids or thymus
• CPC Class Codes: A61B 5/418 lymph vessels, ducts or nodes
• CPC Class Codes: A61B 8/00 Diagnosis using ultrasonic, sonic or infrasonic waves imaging of objects using sonar G01S15/00
• CPC Class Codes: A61B 8/04 Measuring blood pressure
• CPC Class Codes: A61B 8/08 Detecting organic movements or changes, e.g. tumours, cysts, swellings A61B8/02 - A61B8/06 take precedence
• CPC Class Codes: A61B 8/0808 for diagnosis of the brain
• CPC Class Codes: A61B 8/485 involving measuring strain or elastic properties
• CPC Class Codes: A61B 8/488 involving Doppler signals

Abstract

Systems and methods for assessing a physiological parameter of a target tissue wherein a pulse of focused ultrasound is applied to a target tissue site thereby inducing oscillation of the target tissue. By these systems and methods, a property of an acoustic signal emitted from the oscillating target tissue is measured and related to a physiological property of the tissue. Specific applications for systems and methods of the present invention include the assessment and monitoring of intracranial pressure (ICP), arterial blood pressure (ABP), CNS autoregulation status, vasospasm, stroke, local edema, infection and vasculitus, as well as diagnosis and monitoring of diseases and conditions that are characterized by physical changes in tissue properties.

Claims

1. A method for assessing a physiological parameter of a target tissue, comprising the steps of:

(a) applying a pulse of focused ultrasound to a first target tissue site thereby inducing oscillation of said first target tissue site;

(b) measuring a property of an acoustic signal emitted from said oscillating first target tissue site; and

(c) relating the property of the emitted acoustic signal to a physiological tissue property.

2. The method of claim 1, wherein said pulse of focused ultrasound is long enough to create a measurable oscillation of said first target tissue.

3. The method of claim 1, wherein said pulse of focused ultrasound is long enough to create a measurable acoustic emission from said first target tissue.

4. The method of claim 1, wherein said applied focused ultrasound comprises a plurality of acoustic interrogation pulses to said target tissue.

5. The method of claim 4, wherein the repetition frequency of said plurality of acoustic interrogation pulses is large enough to resolve medically interesting temporal features in said first target tissue without inducing a medically unacceptable change in said tissue.

6. The method of claim 5, wherein said plurality of acoustic interrogation pulses comprises a plurality of ultrasound frequencies, wherein every acoustic interrogation pulse is at a single, fixed amplitude and wherein said property of an emitted acoustic signal comprises a maximal and/or minimal amplitude of said emitted acoustic signal.

7. The method of claim 5, wherein said plurality of acoustic interrogation pulses comprises a plurality of ultrasound amplitudes, wherein every acoustic interrogation pulse is at a single, fixed frequency and wherein said property of an emitted acoustic signal comprises a maximal and/or minimal frequency of said emitted acoustic signal.

8. The method of claim 1, wherein said property of an emitted acoustic signal is selected from the group consisting of frequency, amplitude, phase, length relative to an interrogation pulse, and primary amplitude within a cardiac and/or respiratory cycle.

9. The method of claim 1, wherein said property of an acoustic signal emitted from said oscillating target tissue is measured using an ultrasound transducer operating in at least one of the following modes:

transmission mode, reflection mode, scatter mode, backscatter mode, emission mode, echo mode, Doppler mode, color Doppler mode, harmonic or subharmonic imaging modes, a-mode, b-mode or m-mode.

10. The method of claim 1, wherein said target tissue is CNS tissue.

11. The method of claim 10, wherein said CNS tissue is selected from the group consisting of cerebral spinal fluid, brain parenchyma, and cranial nerve.

12. The method of claim 10, wherein said physiological tissue property is intracranial pressure.

13. The method of claim 12, further comprising the step of obtaining a second physiological tissue property selected from the group consisting of an arterial blood pressure, an electrocardiogram, and an electroencephalogram.

14. The method of claim 10, wherein said property of the emitted acoustic signal is the amplitude of said signal and wherein said amplitude of the emitted acoustic signal is related to intracranial pressure.

15. The method of claim 13, further comprising the step of relating said amplitude of the emitted acoustic signal to a second tissue property that is empirically related to intracranial pressure said second tissue property being selected from the group consisting of tissue stiffness, Young'"'"'s modulus, and shear modulus.

16. The method of claim 10, wherein said physiological tissue property is selected from the group consisting of arterial blood pressure and cerebral perfusion pressure.

17. The method of claim 15, wherein said physiological tissue property is arterial blood pressure and wherein said first target tissue site is a blood vessel wall and/or surrounding target tissue.

18. The method of claim 17, wherein said arterial blood pressure is calculated from blood flow velocity and measured by Doppler.

19. The method of claim 18, further comprising the step of acoustically measuring the blood vessel diameter.

20. The method of claim 10, wherein said detected physiological property is selected from the group consisting of:

vasospasm;

stroke;

local edema;

infection;

vasculitus;

subdural or epidural hematomas;

subarachnoid hemorrhages;

ischemic conditions;

multiple sclerosis;

Alzheimers disease;

hypoxic conditions;

intracerebral hemorrhage;

tumors and other intracranial masses; and

acute, chronic and traumatic conditions and injuries.

21. The method of claim 1, wherein said target tissue is peripheral nervous system tissue.

22. The method of claim 1, wherein said property of said emitted acoustic signal is related to an empirically determined standard.

23. The method of claim 1, additionally comprising acquiring multiple data sets, each data set relating to the induced tissue oscillation at different points in time relative to the application of the acoustic radiation force.

24. The method of claim 1, further comprising the steps of:

(a) applying focused ultrasound to a second target tissue site thereby inducing oscillation of said target tissue site;

(b) measuring a property of an acoustic signal emitted from said oscillating second target tissue site; and

(c) comparing said property of an acoustic signal emitted from said oscillating second target tissue site to said property of an acoustic signal emitted from said oscillating first target tissue site; and

(d) relating said compared properties to a physiological tissue property.

25. The method of claim 24, wherein said applied focused ultrasound to said first target tissue site and to said second target tissue site comprises a plurality of acoustic interrogation pulses to said first and said second target tissue sites.

26. The method of claim 25, wherein said plurality of acoustic interrogation pulses comprises a plurality of ultrasound frequencies, wherein every acoustic interrogation pulse is at a single, fixed amplitude and wherein said property of an emitted acoustic signal from said first target tissue site and from said second target tissue site each comprises a unique maximal and/or minimal amplitude of said first and said second emitted acoustic signal.

27. The method of claim 26, wherein the maximal and/or minimal amplitude of said first said second emitted acoustic signals are compared and related to said physiological tissue property.

28. The method of claim 25, wherein said plurality of acoustic interrogation pulses comprises a plurality of ultrasound amplitudes, wherein every acoustic interrogation pulse is at a single, fixed frequency and wherein said property of an emitted acoustic signal from said first target tissue site and from said second target tissue site each comprises a unique maximal and/or minimal frequency of said first and said second emitted acoustic signal.

29. The method of claim 28, wherein the maximal and/or minimal frequency of said first said second emitted acoustic signals are compared and related to said physiological tissue property.

30. The method of claim 1, wherein said first target tissue is a CNS tissue, and wherein said property of an acoustic signal emitted from said oscillating CNS tissue relates to an acoustic property of said target CNS tissue, said method further comprising the step of conducting an initial environmental assessment prior to applying said focused ultrasound to evaluate the characteristics of the environment between the source of said focused ultrasound and said first target tissue site.

31. The method of claim 30, wherein said environment assessment includes a determination of the distance between the source of said focused ultrasound and a physiological structural landmark selected from the group consisting of:

the brain surface, the thickness of the skull, the thickness of the dura mater, the thickness of the arachnoid layer containing cerebral spinal fluid, and cerebral vascular structures.

32. The method of claim 1, wherein said property of an acoustic signal emitted from said oscillating first target tissue site is measured at multiple time points over the course of at least one cardiac cycle, and further comprising the step of correlating said measured property and intrinsic tissue oscillations of said first target tissue with a physiological property of said first target tissue.

33. The method of claim 1, further comprising the steps of:

(a) applying a plurality of focused ultrasound pulses to said first target tissue site; and

(b) measuring one or more property of a plurality of acoustic signals emitted from said oscillating first target tissue site.

34. The method of claim 25, wherein said plurality of focused ultrasound pulses is applied to said first target tissue at a plurality of times.

35. The method of claim 25, further comprising the steps of:

(a) applying a plurality of focused ultrasound pulses to a plurality of target tissue sites; and

(b) measuring one or more property of a plurality of acoustic signals emitted from said plurality of oscillating target tissue sites.

36. The method of claim 1, wherein inducing oscillation of said first target tissue is accomplished by applying an acoustic radiation force using at least two acoustic sources to oscillate said first target tissue.

37. A method for assessing a physiological property of a target tissue, said method comprising the steps of:

(a) acquiring data relating to intrinsic tissue oscillations at a target tissue site at multiple time points over the course of at least one cardiac cycle; and

(b) relating said intrinsic tissue oscillation data with a physiological property of said target tissue.

38. The method of claim 37, further comprising the step of acquiring data relating to intrinsic tissue oscillations at multiple target tissue sites at multiple time points over the course of at least one cardiac cycle.

39. The method of claim 37, wherein said data acquired relating to said intrinsic tissue oscillation at said target tissue site relates to an acoustic property of said target tissue.

40. The method of claim 37, further comprising the step of relating the intrinsic tissue oscillation data and additional data relating to blood pressure, cardiac and/or respiratory cycles to a physiological property of said target tissue.

41. A method for assessing a physiological property of a target tissue, said method comprising the step of combining information from intrinsic tissue displacement and extrinsic induced tissue oscillation or emission.